Published in Vaccine on July 02, 2013
5-fluorouracil-based chemotherapy enhances the antitumor activity of a thymidylate synthase-directed polyepitopic peptide vaccine. J Natl Cancer Inst (2005) 1.59
Epidemiological and clinical study of viral respiratory tract infections in children from Italy. J Med Virol (2009) 1.15
Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial). Clin Cancer Res (2008) 1.15
MicroRNA-sensitive oncolytic measles viruses for cancer-specific vector tropism. Mol Ther (2011) 1.15
Treatment of colon and breast carcinoma cells with 5-fluorouracil enhances expression of carcinoembryonic antigen and susceptibility to HLA-A(*)02.01 restricted, CEA-peptide-specific cytotoxic T cells in vitro. Int J Cancer (2003) 1.10
Serological survey of Toscana virus infections in a high-risk population in Italy. Clin Diagn Lab Immunol (2003) 1.07
A Mediterranean arbovirus: the Toscana virus. J Neurovirol (2003) 1.05
Immune-modulating effects of the newest cetuximab-based chemoimmunotherapy regimen in advanced colorectal cancer patients. J Immunother (2012) 0.97
Artificial riboswitches for gene expression and replication control of DNA and RNA viruses. Proc Natl Acad Sci U S A (2014) 0.96
Different substitutions at conserved amino acids in domains II and III in the Sendai L RNA polymerase protein inactivate viral RNA synthesis. Virology (2002) 0.96
Fast duplex one-step RT-PCR for rapid differential diagnosis of entero- or toscana virus meningitis. Diagn Microbiol Infect Dis (2002) 0.95
Age related changes in T cell mediated immune response and effector memory to Respiratory Syncytial Virus (RSV) in healthy subjects. Immun Ageing (2010) 0.94
Toscana virus induces interferon although its NSs protein reveals antagonistic activity. J Gen Virol (2010) 0.93
A novel armed oncolytic measles vaccine virus for the treatment of cholangiocarcinoma. Hum Gene Ther (2013) 0.93
Caspase-8 and Apaf-1-independent caspase-9 activation in Sendai virus-infected cells. J Biol Chem (2002) 0.92
De novo synthesis of N and P proteins as a key step in Sendai virus gene expression. J Virol (2007) 0.91
Sendai virus vectors as an emerging negative-strand RNA viral vector system. J Gene Med (2003) 0.91
High-affinity HLA-A(*)02.01 peptides from parathyroid hormone-related protein generate in vitro and in vivo antitumor CTL response without autoimmune side effects. J Immunol (2002) 0.90
Granulocyte-macrophage colony-stimulating factor-armed oncolytic measles virus is an effective therapeutic cancer vaccine. Hum Gene Ther (2013) 0.90
Chemovirotherapy of malignant melanoma with a targeted and armed oncolytic measles virus. J Invest Dermatol (2012) 0.88
Negative-strand RNA viral vectors: intravenous application of Sendai virus vectors for the systemic delivery of therapeutic genes. Mol Ther (2003) 0.87
Nucleotide variability of Toscana virus M segment in strains isolated from clinical cases. Virus Res (2008) 0.86
Efficient propagation of single gene deleted recombinant Sendai virus vectors. Virus Res (2004) 0.85
Chemotherapeutic drugs may be used to enhance the killing efficacy of human tumor antigen peptide-specific CTLs. J Immunother (2008) 0.85
Recombinant Sendai virus induces T cell immunity against respiratory syncytial virus that is protective in the absence of antibodies. Cell Immunol (2007) 0.85
Human bocavirus detection in an atopic child affected by pneumonia associated with wheezing. J Clin Virol (2007) 0.84
Toscana virus NSs protein inhibits the induction of type I interferon by interacting with RIG-I. J Virol (2013) 0.83
A chimeric respiratory syncytial virus fusion protein functionally replaces the F and HN glycoproteins in recombinant Sendai virus. J Virol (2005) 0.82
A polyepitope DNA vaccine targeted to Her-2/ErbB-2 elicits a broad range of human and murine CTL effectors to protect against tumor challenge. Cancer Res (2007) 0.81
Immunomodulatory properties of anticancer monoclonal antibodies: is the 'magic bullet' still a reliable paradigm? Immunotherapy (2011) 0.81
Seroprevalence of and risk factors for Toscana and Sicilian virus infection in a sample population of Sicily (Italy). J Infect (2011) 0.81
Prevalence of toscana and sicilian phlebovirus antibodies in classic Kaposi sarcoma case patients and control subjects in sicily. J Infect Dis (2011) 0.81
Sendai virus trailer RNA simultaneously blocks two apoptosis-inducing mechanisms in a cell type-dependent manner. J Gen Virol (2005) 0.80
Enhanced killing of therapy-induced senescent tumor cells by oncolytic measles vaccine viruses. Int J Cancer (2013) 0.80
Immunization with Toscana virus N-Gc proteins protects mice against virus challenge. Virology (2008) 0.79
Cell cycle independent infection and gene transfer by recombinant Sendai viruses. J Virol Methods (2003) 0.79
Chemo-immunotherapy of colorectal carcinoma: preclinical rationale and clinical experience. Invest New Drugs (2006) 0.78
Immunoglobulin M seropositivity for Toscana virus in a random population sample in Sicily. Int J Infect Dis (2012) 0.78
Anti-angiogenetic effects of immune-reconstituted influenza virosomes assembled with parathyroid hormone-related protein derived peptide vaccine. Cancer Lett (2008) 0.78
Serological and molecular detection of Toscana and other Phleboviruses in patients and sandflies in Tunisia. BMC Infect Dis (2014) 0.77
Severe impairment of dendritic cell allostimulatory activity by Sendai virus vectors is overcome by matrix protein gene deletion. J Immunol (2005) 0.77
Recombinant Sendai virus for efficient gene transfer to human airway epithelium. Exp Lung Res (2004) 0.77
Molecular detection of measles virus in primary cell cultures of otosclerotic tissue. Acta Otolaryngol (2006) 0.76
Evaluation of nucleocapsid and phosphoprotein p functionality as critical factors during the early phase of paramyxoviral infection. Open Virol J (2012) 0.75
Why is influenza virus more risky for pregnant women? Influenza Other Respir Viruses (2010) 0.75
EBV Reactivation and Chromosomal Polysomies: Euphorbia tirucalli as a Possible Cofactor in Endemic Burkitt Lymphoma. Adv Hematol (2012) 0.75
Histological description of the lymphadenopathy related to Toscana virus infection. Report of a case. Pathol Res Pract (2010) 0.75
Comparison of a new prototype immunochromatographic assay and a commercial enzyme-linked immunosorbent assay for the detection of serum antibodies against Toscana virus. J Virol Methods (2012) 0.75
Bayesian skyline plot inference of the Toscana virus epidemic: a decline in the effective number of infections over the last 30 years. Infect Genet Evol (2009) 0.75
HCMV infection in renal transplant recipients: a retrospective cohort study. New Microbiol (2013) 0.75